BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22151793)

  • 21. Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations.
    Grinblat B; Galimberti G; Chouela E; Sanclemente G; Lopez M; Alcala D; Torezan L; Pantoja G
    Photodermatol Photoimmunol Photomed; 2016 Mar; 32(2):81-7. PubMed ID: 26541910
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Daylight photodynamic therapy for actinic keratosis: an international consensus: International Society for Photodynamic Therapy in Dermatology.
    Wiegell SR; Wulf HC; Szeimies RM; Basset-Seguin N; Bissonnette R; Gerritsen MJ; Gilaberte Y; Calzavara-Pinton P; Morton CA; Sidoroff A; Braathen LR
    J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):673-9. PubMed ID: 22211665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome.
    Ericson MB; Sandberg C; Stenquist B; Gudmundson F; Karlsson M; Ros AM; Rosén A; Larkö O; Wennberg AM; Rosdahl I
    Br J Dermatol; 2004 Dec; 151(6):1204-12. PubMed ID: 15606516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients.
    Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W
    Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of actinic keratoses on the dorsum of the hands: ALA-PDT versus diclofenac 3% gel followed by ALA-PDT. A placebo-controlled, double-blind, pilot study.
    Van der Geer S; Krekels GA
    J Dermatolog Treat; 2009; 20(5):259-65. PubMed ID: 19370466
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ambulatory photodynamic therapy using low irradiance inorganic light-emitting diodes for the treatment of non-melanoma skin cancer: an open study.
    Ibbotson SH; Ferguson J
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):235-9. PubMed ID: 22971187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of photodynamic therapy with a self-adhesive 5-aminolaevulinic acid patch: 12 months data.
    Szeimies RM; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Hauschild A
    Br J Dermatol; 2010 Feb; 162(2):410-4. PubMed ID: 19804593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis.
    Liew YCC; De Souza NNA; Sultana RG; Oh CC
    J Eur Acad Dermatol Venereol; 2020 Feb; 34(2):251-259. PubMed ID: 31394005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized, double-blind, prospective study to compare topical 5-aminolaevulinic acid methylester with topical 5-aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis.
    Moloney FJ; Collins P
    Br J Dermatol; 2007 Jul; 157(1):87-91. PubMed ID: 17501954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative study between cold air analgesia and supraorbital and supratrochlear nerve block for the management of pain during photodynamic therapy for actinic keratoses of the frontotemporal zone.
    Serra-Guillen C; Hueso L; Nagore E; Vila M; Llombart B; Requena Caballero C; Botella-Estrada R; Sanmartin O; Alfaro-Rubio A; Guillen C
    Br J Dermatol; 2009 Aug; 161(2):353-6. PubMed ID: 19438468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective, case-based assessment of sequential therapy with topical Fluorouracil cream 0.5% and ALA-PDT for the treatment of actinic keratosis.
    Martin G
    J Drugs Dermatol; 2011 Apr; 10(4):372-8. PubMed ID: 21455547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of different fluence rates on pain and clinical outcome in patients with actinic keratoses treated with photodynamic therapy.
    Apalla Z; Sotiriou E; Panagiotidou D; Lefaki I; Goussi C; Ioannides D
    Photodermatol Photoimmunol Photomed; 2011 Aug; 27(4):181-5. PubMed ID: 21729165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Taking treatment decisions in non-melanoma skin cancer--the place for topical photodynamic therapy (PDT).
    Sidoroff A; Thaler P
    Photodiagnosis Photodyn Ther; 2010 Mar; 7(1):24-32. PubMed ID: 20230990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patients' experiences of pain and pain relief during photodynamic therapy on actinic keratoses: an interview study.
    Halldin CB; Gonzalez H; Wennberg AM; Lepp M
    Acta Derm Venereol; 2013 Jul; 93(4):433-7. PubMed ID: 23224121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe cutaneous reaction to photodynamic therapy with blue light.
    Moore MM; Reyna C; Hope RH
    J Drugs Dermatol; 2011 Sep; 10(9):1057-8. PubMed ID: 22052277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: a randomized, intraindividual comparison trial with 12-month follow-up.
    Sotiriou E; Apalla Z; Chovarda E; Goussi C; Trigoni A; Ioannides D
    J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):36-40. PubMed ID: 21366709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short incubation PDT versus 5-FU in treating actinic keratoses.
    Smith S; Piacquadio D; Morhenn V; Atkin D; Fitzpatrick R
    J Drugs Dermatol; 2003 Dec; 2(6):629-35. PubMed ID: 14711141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nerve blocks enable adequate pain relief during topical photodynamic therapy of field cancerization on the forehead and scalp.
    Halldin CB; Paoli J; Sandberg C; Gonzalez H; Wennberg AM
    Br J Dermatol; 2009 Apr; 160(4):795-800. PubMed ID: 19210497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study.
    Szeimies RM; Radny P; Sebastian M; Borrosch F; Dirschka T; Krähn-Senftleben G; Reich K; Pabst G; Voss D; Foguet M; Gahlmann R; Lübbert H; Reinhold U
    Br J Dermatol; 2010 Aug; 163(2):386-94. PubMed ID: 20518784
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary prevention of skin dysplasia in renal transplant recipients with photodynamic therapy: a randomized controlled trial.
    Togsverd-Bo K; Omland SH; Wulf HC; Sørensen SS; Haedersdal M
    Am J Transplant; 2015 Nov; 15(11):2986-90. PubMed ID: 26018207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.